Company Luckwel Pharmaceuticals Inc. Other OTC
Equities
LWEL
US54959L1017
Investment Holding Companies
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kingrich Lee
CEO | Chief Executive Officer | 49 | 02/13/02 |
Mark Carrao
DFI | Director of Finance/CFO | - | 01/21/01 |
Chief Tech/Sci/R&D Officer | - | - | |
Priya Jambhekar
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kingrich Lee
CEO | Chief Executive Officer | 49 | 02/13/02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 147,163,500 | 14,931,388 ( 10.15 %) | 0 | 10.15 % |
Company contact information
Luckwel Pharmaceuticals, Inc.
125 Cambridge Park Drive Suite 301
02140, Cambridge
+617 430 5222
http://www.luckwel.com![address Luckwel Pharmaceuticals Inc.(LWEL)](https://cdn.zonebourse.com/static/address/111314097.png)
1st Jan change | Capi. | |
---|---|---|
+109.89% | 693.55Cr | |
+98.02% | 124.97Cr | |
+2.95% | 99Cr | |
+26.90% | 81Cr | |
+2.20% | 67Cr | |
+3.23% | 60Cr | |
-.--% | 60Cr | |
+10.28% | 54Cr | |
-.--% | 50Cr |